Viewing Study NCT02630251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-02-25 @ 11:01 PM
Study NCT ID: NCT02630251
Status: TERMINATED
Last Update Posted: 2020-02-12
First Post: 2015-11-30
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer View
None Safety View
None GSK2820151 View
None Dose escalation View
None Tolerability View
None Pharmacodynamics View
None Pharmacokinetics View